These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 18653248)

  • 21. [The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases].
    Motomura M
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1237-9. PubMed ID: 10791087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
    Honnorat J
    Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient subacute cerebellar ataxia in a patient with Lambert-Eaton myasthenic syndrome after intracranial aneurysm surgery.
    Nakamura M; Yabe I; Sato K; Nakano F; Yaguchi H; Tsuji S; Shiraishi H; Yoneda M; Tanaka K; Motomura M; Sasaki H
    Clin Neurol Neurosurg; 2008 May; 110(5):480-3. PubMed ID: 18295972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lambert-Eaton Myasthenic Syndrome].
    Matsuo H
    Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome.
    Takamori M
    Intern Med; 1999 Feb; 38(2):86-96. PubMed ID: 10225662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lambert-Eaton myasthenic syndrome. Clinical and electrophysiological findings in seven cases.
    Zambelis T; Foutsitzi A; Giannakopoulou A; Poulopoulou K; Karandreas N
    Electromyogr Clin Neurophysiol; 2004; 44(5):289-92. PubMed ID: 15378868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
    Schoser B; Eymard B; Datt J; Mantegazza R
    J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biochemical approaches to neuromuscular junction disorders].
    Takamori M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1363-4. PubMed ID: 9128412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
    Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
    Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Response to immunoadsorption and steroid therapies in a patient with carcinomatous Lambert-Eaton myasthenia syndrome accompanied by disturbed consciousness].
    Ishikawa S; Takei Y; Tokunaga S; Motomura M; Nakao Y; Hanyu N
    Rinsho Shinkeigaku; 2000 May; 40(5):459-63. PubMed ID: 11002728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advance in research for myasthenia gravis, in relation to various antibodies affecting synaptic structure and function].
    Takamori M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):789-93. PubMed ID: 20030211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.